BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...

WASHINGTON, DC—For vascular closure after transfemoral TAVI, a strategy that combines suture- and plug-based devices halves the risk of access site-related vascular complications during a patient’s’ ...

CHARLOTTE, N.C., March 27, 2025 /PRNewswire/ -- Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug ...

Registry Intends to Examine Contemporary On-Label Use of the MANTA™ Vascular Closure Device Including Appropriate Patient Selection and Proper Vascular Access WAYNE, Pa., Nov. 16, 2023 (GLOBE NEWSWIRE ...

The Department of Medicine is proud to celebrate the Electrophysiology Team for being the first in the world to perform a procedure using a new vascular closure system. The new device helps stop ...

BOSTON, June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a ...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that it will unveil the results of its U.S ...

For patients undergoing coronary procedures via transfemoral access, ultrasound guidance decreases the combined outcome of major vascular complications or bleeding and is particularly valuable when ...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced initial positive results from its U.S. IDE ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Rates of patency and device-related thrombus were ...